Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.

about

Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine.Efficient inhibition of cervical cancer by dual drugs loaded in biodegradable thermosensitive hydrogel composites.

P2860

Q47935425-F3FC25C0-F8A5-41C2-9833-BA83F783CB96 Q49882454-C26E4F22-04AA-494D-95AF-930A25790E95

P2860

Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.

Item

http://www.wikidata.org/entity/Q38630235

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel composite drug delivery ...... eatment of cervical carcinoma.

@en

type

Item

label

Novel composite drug delivery ...... eatment of cervical carcinoma.

@en

prefLabel

Novel composite drug delivery ...... eatment of cervical carcinoma.

@en

P1476

Novel composite drug delivery ...... eatment of cervical carcinoma.

@en

P2093

Heng Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Bo Wu

http://www.w3.org/2001/XMLSchema#string

Jing Pin Yang

http://www.w3.org/2001/XMLSchema#string

Ling Lin Yang

http://www.w3.org/2001/XMLSchema#string

Qin Yun

http://www.w3.org/2001/XMLSchema#string

Qiuxia Peng

http://www.w3.org/2001/XMLSchema#string

Shan Xu

http://www.w3.org/2001/XMLSchema#string

ShaoZhi Fu

http://www.w3.org/2001/XMLSchema#string

Xiaoyang Sun

http://www.w3.org/2001/XMLSchema#string

Yan Xin Yu

http://www.w3.org/2001/XMLSchema#string

P2860

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

ATM phosphorylates histone H2AX in response to DNA double-strand breaks

Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial.

Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care.

Paclitaxel (taxol)

ALDH1 might influence the metastatic capability of HeLa cells.

A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer.

Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.

The potentiation of the effect of radiation treatment by intratumoral delivery of cisplatin.

P304

1139-1147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10717544.2017.1362676

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28797171

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.

about

P2860

P2860

Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921